Webinar | July 17, 2019

How Molecular Structure Influences Potency Of A Therapeutic Biologic

Source: MilliporeSigma

Monoclonal antibodies are a rapidly expanding sector. These drugs are complex in their structure and their mode of actions. This webinar takes a closer look at one of these drugs: Humira® (Adalimumab). The focus of this presentation is glycans. We will look at how to choose an analytical method and how changes to these glycan molecules affect the biological activity of the drugs. In this webinar, MilliporeSigma scientists, ranging in specialty from analytical to immuno-focused, give the listener an understanding of how an antibody’s molecular structure, of which there are many measurable properties that can be measured, influences its binding and affects potency of a therapeutic biologic.

VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: